Search Results 371-380 of 18228 for total bilirubin

  1. A Study to Evaluate the Disease Development and Impact of Intravascular Volume Expansion Profiles in Relation to Neuroendocrine and Renal Function in Post-Acute Heart Failure - Mayo Clinic

    ... bilirubin three times or more the upper limit of normal. ... In this context, neither total extracellular fluid volume nor total blood volume are determinants of ...

  2. A Study of Olezarsen (ISIS 678354) Administered to Participants With Severe Hypertriglyceridemia - Mayo Clinic

    - Total bilirubin > upper limit of normal unless due to Gilbert's syndrome. - Estimated GFR < 30 mL/min/1.73 m^2. Note: Other protocol defined Inclusion ...

  3. Phase IIa Study Evaluating Safety and Efficacy of BL-8040 in Relapsed/Refractory AML Patients - Mayo Clinic

    Serum bilirubin. Total bilirubin > 2.0 mg/dL (34 µmol/L), conjugated bilirubin > 0.8 mg/dL. Left ventricular ejection fraction < 40 %. History of myocardial ...

  4. A Study of Using Caspofungin Acetate or Fluconazole in Preventing Invasive Fungal Infections in Patients with Acute Myeloid Leukemia Who Are Undergoing Chemotherapy - Mayo Clinic

    Total bilirubin ≤ 1.5 x upper limit of normal (ULN) for age; Serum glutamic oxaloacetic transaminase (SGOT) (aspartate aminotransferase [AST]) or serum ...

  5. A Study to Evaluate Combination Therapy to Treat Newly-diagnosed Diffuse Anaplastic Wilms Tumors and Relapsed Favorable Histology Wilms Tumors A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT - Mayo Clinic

    Total bilirubin ≤ 1.5 x upper limit of normal (ULN) for age or direct bilirubin ≤ ULN for patients whose total bilirubin > 1.5 x ULN (performed within 7 days ...

  6. A Study of Napabucasin Plus Nab-Paclitaxel With Gemcitabine in Adult Patients With Metastatic Pancreatic Adenocarcinoma - Mayo Clinic

    Total bilirubin ≤ 1.5 x institutional ULN. If total bilirubin is > ULN, it must be non-rising for at least 7 days. Serum creatinine within normal limits or ...

  7. A Study to Evaluate the Safety and Effectiveness of Tildacerfont to Reduce Glucocorticoid Use in Classic Congenital Adrenal Hyperplasia - Mayo Clinic

    Total bilirubin >1.5 x ULN (isolated total bilirubin >1.5 x ULN is acceptable if bilirubin is fractionated and direct bilirubin is 5 x ULN Routinely works ...

  8. A Study to Evaluate the Safety, Effectiveness, and Tolerability of Latiglutenase to Treat Patients with Well-Controlled Celiac Disease - Mayo Clinic

    Total bilirubin > 1.5x ULN;; Serum creatinine > 1.5x ULN;; Hemoglobin < 10 g/dL or 100 g/L;; Calcium < 8.0 mg/mL;; Platelet count< 75.0 x 109/L or 75,000/mm3 ...

  9. Pharmacokinetic and Safety Study of Nab ®-Paclitaxel (ABI-007) Plus Gemcitabine in Subjects with Advanced Pancreatic Cancer Who Have Cholestatic Hyperbilirubenemia - Mayo Clinic

    In addition, there should be no complications (eg, infection) present and bilirubin levels should have stabilized (2 readings with total bilirubin within 20% of ...

  10. Nivolumab in Treating Patients With Recurrent and/or Metastatic Nasopharyngeal Cancer - Mayo Clinic

    Serum total bilirubin < 2 x ULN (except patients with Gilbert syndrome, who can have total bilirubin < 3.0 mg/dL); Serum creatinine < 1.5 x ULN. Exclusion ...